Allergy Therapeutics
Worthing
About Allergy Therapeutics
They have provided general information for the allergy sufferer and healthcare professionals about the prevention, diagnosis and treatment of the allergic condition with a special focus on allergy vaccination (also known as specific immunotherapy or desensitisation therapy), the only treatment to deal with the underlying cause and not just the symptoms!
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 501 – 1,000
- Estimated revenue: $50K – $100K
- Total funding: $168.5M
- Funding stage: IPO
- Last round: Post-IPO Equity (Oct 2025)
- Ticker: lse:AGY
- Website: allergytherapeutics.com
- Phone: +4401903844700
Industries & Categories
Health Care, Health Diagnostics, Medical
Social Profiles
Canonical: https://fsome.com/organization/allergy-therapeutics-20606 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.